Drug
Evo756
Evo756: highest development phase Phase 2, developed by Evommune, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Evommune, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| EVO756, Dose 1 NCT07616128 | Phase 2 | Migraine |
Latest
No recent events.
Follow Evo756 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.